Cordyceps Sunshine Biotech Holdings (RAJAF) Finished Goods (2020 - 2022)

Cordyceps Sunshine Biotech Holdings' Finished Goods history runs 3 years deep, the most recent figure standing at $207645.0 for Q4 2022.

• In Q4 2022, Finished Goods fell 55.48% year-over-year to $207645.0; the TTM figure through Dec 2022 stood at $207645.0 (down 55.48% YoY), while the FY2022 annual figure was $207645.0, down 55.48% from the prior year.
• Finished Goods was $207645.0 for Q4 2022 at Cordyceps Sunshine Biotech Holdings, down from $466449.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $466449.0 in Q4 2021 to a low of $20328.0 in Q4 2020.
• Historically, Finished Goods has averaged $231474.0 across 3 years, with a median of $207645.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Finished Goods soared 2194.61% in 2021, then sank 55.48% in 2022.
• A 3-year view of Finished Goods shows it stood at $20328.0 in 2020, then jumped by 2194.61% to $466449.0 in 2021, then tumbled by 55.48% to $207645.0 in 2022.
• The last three Finished Goods figures came in at $207645.0 (Q4 2022), $466449.0 (Q4 2021), and $20328.0 (Q4 2020), per Business Quant data.